Lombard-based Pinnacle Dermatology has acquired Bolingbrook Dermatology, further expanding its presence in the Chicago region.
Pinnacle has been a portfolio company of Chicago Pacific Founders since 2017. Bolingbrook Dermatology is a practice founded and led by board-certified dermatologist Dr. Tehming Liang. Financial terms were not disclosed.
“Over the past 24 years, Dr. Liang has established a strong practice dedicated to providing excellence in medical and surgical dermatologic care for patients,” Pinnacle Dermatology CEO Chad A. Eckes said in a statement. “Additionally, Pinnacle Dermatology and Bolingbrook Dermatology have established a strong relationship over the years with Dr. Liang referring many patients requiring Mohs surgery to Pinnacle. This relationship, along with our shared values, make the practice a perfect fit to take our partnership to the next level.”
Dr. Liang earned his medical degree from the University of Miami Miller School of Medicine in 1987. After completing his residency at the University of Chicago, he taught for four years at Wright State University in Dayton, Ohio and served as the interim chairman and director of the dermatology residency program. In 1995, Dr. Liang returned to the Chicago area to open Bolingbrook Dermatology. He is a member of the American Academy of Dermatology, American Medical Association, Chicago Society of Dermatology and the Illinois Dermatologic Association.
The deal is part of Pinnacle Dermatology’s strategy to build a strong, multi-site dermatology practice operating in multiple geographic markets. Currently, the company has offices in Illinois, Indiana, Michigan and Minnesota. Responsive patient care, including same-day appointments, patient education and a commitment to provide screening for the early detection of skin cancer, are seen as key elements to the practice.
Pinnacle Dermatology will continue serving the patients of Bolingbrook Dermatology at the current location and medical insurance coverage will remain the same. Pinnacle has raised one private equity round for an undisclosed sum and made two acquisitions prior to the deal to buy Bolingbrook, according to Crunchbase.
